Tiludronate disodium hemihydrate thalene is a novel drug that

is a novel drug that is currently in clinical development by Bayer

InChiKey: JUPOTOIJLKDAPF-UHFFFAOYSA-N

and 16 nM

Smiles: CCCS(=O)(=O)C1=NC(=CC(NC2CC2)=N1)C1C=C2C=CN(C3CC(C)(C)NC(C)(C)C3)C2=CC=1

InChi: InChI=1S/C14H9I3O4/c15-9-6-8(1-2-12(9)18)21-14-10(16)3-7(4-11(14)17)5-13(19)20/h1-4

Tiludronate disodium hemihydrate thalene is a novel drug thatTiludronate (Tiludronic Acid) disodium hemihydrate, an orally active bisphosphonate, can act an osteoregulator. Tiludronate disodium hemihydrate is used for the research of the metabolic bone disorders. Tiludronate disodium hemihydrate is a potent inhibitor of the osteoclast vacuolar H+ ATPase. Antiresorptive and anti inflammatory properties. Product information CAS Number: 155453 10 4 Molecular Weight: 743. 16 Formula: C14H16Cl2Na4O13P4S2 Chemical